Sodium amylobarbitone in the differential diagnosis of confusion



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Ward, N. G.
	Articles by Burke, P.
	Search for Related Content



	PubMed Citation
	Articles by Ward, N. G.
	Articles by Burke, P.

Am J Psychiatry 1978; 135:75-78
Copyright © 1978 by American Psychiatric Association

REGULAR ARTICLES

Sodium amylobarbitone in the differential diagnosis of confusion

NG Ward, DB Rowlett and P Burke

The authors describe the use of intravenous sodium amylobarbitone to differentiate between functional and organic confusion. Four psychiatric patients with functional confusion developed a clear sensorium on this drug. Since previous studies have demonstrated that organic confusion is increased by sodium amylobarbitone, the authors conclude that the drug can be an aid in the differential diagnosis of confusion. They discuss possible applications.

This article has been cited by other articles:

E. V. Beresin
Delirium in the Elderly
J Geriatr Psychiatry Neurol, July 1, 1988; 1(3): 127 - 143.
[Abstract] [PDF]

Get information about faster international access.